Home Contact us Sitemap Our Company Our Products Quality Control Our Research News & Media Careers Recent News December 15, 2015 Indication for Monofer®▼ (iron isomaltoside 1000, 100 mg/ml) is widened and can be prescribed to adult patients with iron deficiency December 15, 2015 Celebrating 50 years July 14, 2015 Pharmacosmos introduces DEAE-Dextran Committed to Quality Pharmacosmos develops and markets medicines for the treatment of iron deficiency. An independent pharmaceutical company with an ongoing R&D programme, our goal is to improve iron therapy options for patients and healthcare professionals. Our second focus area, we develop and market high quality dextran biopolymers for pharmaceutical and life science products. Read more about our company and our products. Our BrandsSee all Brands Read about Monofer® Read about Diafer® Read about CosmoFer® Read about Uniferon® Read about Dextran® Pharmacosmos A/S | Roervangsvej 30 | DK-4300 Holbaek | T: +45 59 48 59 59 | E: info@pharmacosmos.com Disclaimer Privacy statement About this site © 2016 PHARMACOSMOS A/S This website contains information on products which is targeted to a wide range of audiences outside US and may contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Monofer®, CosmoFer® and Uniferon® are a registered trademarks of Pharmacosmos A/S. All rights reserved.

Home Contact us Sitemap Our Company Our Products Quality Control Our Research News & Media Careers Our Company Company profile Board of directors Management Mission Vision & strategy Manufacturing facilities Our history Company profile Specialist in treatment of iron deficiency anaemia and clinical grade dextran biopolymers Pharmacosmos is a privately-owned, specialist pharmaceutical company established in 1965 by Dr. Henry M. Christensen M.D. and is specialized in: Treatment of iron deficiency anaemia in humans Treatment of iron deficiency anaemia in animals High quality, clinical grade dextran biopolymers Our corporate headquarter is located in Denmark, Scandinavia, where we manufacture and develop treatments of iron deficiency anemia in humans and animals. Pharmacosmos A/S | Roervangsvej 30 | DK-4300 Holbaek | T: +45 59 48 59 59 | E: info@pharmacosmos.com Disclaimer Privacy statement About this site © 2016 PHARMACOSMOS A/S This website contains information on products which is targeted to a wide range of audiences outside US and may contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Monofer®, CosmoFer® and Uniferon® are a registered trademarks of Pharmacosmos A/S. All rights reserved.